back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-02 17:24 Tx date 2026-02-27 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$76,041
+26,300 vol $2.89 each |
325,424 | |
| Filed 2026-02-27 16:17 Tx date 2026-02-26 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,508
+3,700 vol $2.84 each |
299,124 | |
| Filed 2025-12-30 09:55 Tx date 2025-12-19 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,925
+1,504 vol $2.61 each |
295,424 | |
| Filed 2025-12-30 09:54 Tx date 2025-12-19 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-6,605.91
-2,531 vol $2.61 each |
32,596 | |
| Filed 2025-12-30 09:47 Tx date 2025-12-23 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR 2017 INC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,318
+16,600 vol $2.73 each |
35,000 | |
| Filed 2025-12-30 09:47 Tx date 2025-12-22 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR 2017 INC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,128
+18,400 vol $2.67 each |
18,400 | |
| Filed 2025-12-30 09:46 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR 2017 INC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-29 08:46 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$53,055
+17,804 vol $2.98 each |
293,920 | |
| Filed 2025-09-29 08:45 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-17,804 vol |
35,127 | |
| Filed 2025-09-29 08:44 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-21,302 vol |
52,931 | |
| Filed 2025-09-29 08:43 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+32,596 vol |
74,233 | |
| Filed 2025-08-21 16:16 Tx date 2025-08-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$87,561
+30,000 vol $2.92 each |
134,891 | |
| Filed 2024-12-10 17:00 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-7,353 vol |
0 | |
| Filed 2024-12-10 16:59 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - TFSA (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-3,922 vol |
0 | |
| Filed 2024-12-10 16:59 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-4,902 vol |
0 | |
| Filed 2024-12-10 16:58 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: JARR Family Trust (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-10,784 vol |
0 | |
| Filed 2024-12-10 16:50 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Stephen & Kathryn Nelson - RESP (Control or Direction)
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$75,000 vol |
$0 | |
| Filed 2024-12-10 16:49 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$50,000 vol |
$0 | |
| Filed 2024-12-10 16:48 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Holder: Kathryn Nelson - RRSP (Control or Direction)
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$100,000 vol |
$0 | |
| Filed 2024-12-10 16:48 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Nelson, Stephen William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$71,000 vol |
$0 |